Acadian Asset Management
PRQR icon

Acadian Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Acadian Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-93,358
Closed -$165K – 2053
2024
Q3 		$165K Buy
93,358
+89,425
+2,274% +$168K ﹤0.01% 1427
2024
Q2 		$6K Sell
3,933
-20,830
-84% -$40.4K ﹤0.01% 1713
2024
Q1 		$56K Buy
+24,763
New +$52.9K ﹤0.01% 1368
2023
Q1 		– Sell
-17,256
Closed -$63K – 1918
2022
Q4 		$63K Sell
17,256
-169,778
-91% -$222K ﹤0.01% 1532
2022
Q3 		$138K Buy
+187,034
New +$150K ﹤0.01% 1290
2022
Q2 		– Sell
-8,925
Closed -$8K – 1823
2022
Q1 		$8K Buy
+8,925
New +$29.9K ﹤0.01% 1602
2021
Q3 		– Sell
-3,645
Closed -$25K – 1958
2021
Q2 		$25K Buy
+3,645
New +$23.5K ﹤0.01% 1917
2018
Q1 		– Sell
-100
Closed – – 1798
2017
Q4 		$0 Hold
100
– – ﹤0.01% 1654
2017
Q3 		$0 Buy
+100
New +$519 ﹤0.01% 1510
2017
Q1 		– Sell
-6,422
Closed -$31K – 1727
2016
Q4 		$31K Buy
+6,422
New +$33.1K ﹤0.01% 1255
2015
Q3 		– Sell
-18,152
Closed -$303K – 1401
2015
Q2 		$303K Buy
+18,152
New +$342K ﹤0.01% 866

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management's PRQR Position: Q4 2024 in Review

Acadian Asset Management sold out of ProQR Therapeutics (PRQR) in Q4 2024, closing a stake of 93,358 shares — an estimated $165K sold.

Acadian Asset Management first reported a position in PRQR in Q2 2015 and held it in 11 quarters. The position peaked at $303K in Q2 2015. 77 funds tracked by Wall St. Rank hold PRQR as of Q4 2024.

  • Acadian Asset Management reported no remaining ProQR Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 93,358 ProQR Therapeutics shares in Q4 2024, an estimated $165K.
  • Acadian Asset Management first reported a position in ProQR Therapeutics in Q2 2015 and held it in 11 quarters.
  • Acadian Asset Management's ProQR Therapeutics position peaked at $303K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.